Prothena Corporation PLC (PRTA)’s Amyloidosis Pipeline In Focus

Prothena Corporation PLC (NASDAQ:PRTA) just offered up some insight into its ongoing phase I/II in its lead candidate, NEOD001.

Keep Reading →